{"transactions":[{"id":4633527,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-01T15:57:11.000Z","date":"2026-09-30","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.92,"value":92000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.91 to $0.93 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":1337964,"source":{"system":"sec-edgar","filing":"0001437749-26-031654","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926031654/rdgdoc.xml","form_type":"4"}},{"id":4633526,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-01T15:57:11.000Z","date":"2026-09-29","kind":"purchase","planned":false,"acquired":true,"shares":206813,"price":0.9,"value":186131.7,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.86 to $0.94 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":1237964,"source":{"system":"sec-edgar","filing":"0001437749-26-031654","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926031654/rdgdoc.xml","form_type":"4"}},{"id":4633528,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-01T00:03:57.000Z","date":"2026-09-28","kind":"purchase","planned":false,"acquired":true,"shares":93091,"price":0.84,"value":78196.44,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.82 to $0.85 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":1031151,"source":{"system":"sec-edgar","filing":"0001437749-26-031597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926031597/rdgdoc.xml","form_type":"4"}},{"id":989117,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":72607,"kind":"person","name":"Anderson Robert Eugene Jr","position":1,"cik":"0002001911","reported_name":"Anderson Robert Eugene Jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-25T21:06:25.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":8600,"price":2.9,"value":24940.0,"ownership":{"direct":true},"balance_after":8600,"source":{"system":"sec-edgar","filing":"0001437749-25-036321","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925036321/rdgdoc.xml","form_type":"4"}},{"id":990540,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-24T21:02:17.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":2.76,"value":414000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.74 to $2.80 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":938060,"source":{"system":"sec-edgar","filing":"0001437749-25-036125","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925036125/rdgdoc.xml","form_type":"4"}},{"id":992952,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-20T22:39:26.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":73385,"price":2.75,"value":201808.75,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.73 to $2.75 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":788060,"source":{"system":"sec-edgar","filing":"0001437749-25-035882","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925035882/rdgdoc.xml","form_type":"4"}},{"id":1014942,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":44451,"kind":"person","name":"Bir Dawn Carter","position":1,"cik":"0001688712","reported_name":"Bir Dawn Carter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-22T22:15:16.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":53000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-10-21","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0001437749-25-031540","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925031540/rdgdoc.xml","form_type":"4"}},{"id":1028087,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":74697,"kind":"person","name":"Cook Robert Christopher","position":1,"cik":"0001952028","reported_name":"Cook Robert Christopher","relationship":{"officer":true,"officer_title":"Chief Operating & Legal Office"}}],"security":"Common Stock","published_at":"2025-10-02T20:44:48.000Z","date":"2025-09-30","kind":"purchase","planned":false,"acquired":true,"shares":13725,"price":2.91,"value":39939.75,"ownership":{"direct":true},"balance_after":13725,"source":{"system":"sec-edgar","filing":"0001437749-25-030348","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925030348/rdgdoc.xml","form_type":"4"}},{"id":1033945,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-23T20:06:41.000Z","date":"2025-09-22","kind":"purchase","planned":false,"acquired":true,"shares":7172,"price":2.28,"value":16352.16,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.27 to $2.29 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":714675,"source":{"system":"sec-edgar","filing":"0001437749-25-029725","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029725/rdgdoc.xml","form_type":"4"}},{"id":1035002,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-19","kind":"purchase","planned":false,"acquired":true,"shares":46908,"price":2.29,"value":107419.32,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":707503,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1035001,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-19","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":2.25,"value":900.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":660595,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1035000,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-18","kind":"purchase","planned":false,"acquired":true,"shares":185233,"price":2.24,"value":414921.92,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":660195,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1034999,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-18","kind":"purchase","planned":false,"acquired":true,"shares":5400,"price":2.13,"value":11502.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":474962,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1086861,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":77488,"kind":"person","name":"SCANNON PATRICK J MD PHD","position":1,"cik":"0001222790","reported_name":"SCANNON PATRICK J MD PHD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-16T20:04:20.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-022829","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925022829/rdgdoc.xml","form_type":"4"}},{"id":1133958,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":72607,"kind":"person","name":"Anderson Robert Eugene Jr","position":1,"cik":"0002001911","reported_name":"Anderson Robert Eugene Jr","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-27T20:26:31.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-018505","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018505/rdgdoc.xml","form_type":"4"}},{"id":1133957,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":30157,"kind":"person","name":"Gravier Pierre","position":1,"cik":"0001984065","reported_name":"Gravier Pierre","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-27T20:23:30.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-018503","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018503/rdgdoc.xml","form_type":"4"}},{"id":1133955,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-27T20:21:32.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-018500","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018500/rdgdoc.xml","form_type":"4"}},{"id":1133956,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-27T20:19:35.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-018497","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018497/rdgdoc.xml","form_type":"4"}},{"id":1133954,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79269,"kind":"person","name":"O DONNELL  MICHAEL J","position":1,"cik":"0001245266","reported_name":"O DONNELL  MICHAEL J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-27T20:17:01.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-018494","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018494/rdgdoc.xml","form_type":"4"}},{"id":1168707,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T20:51:38.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026."}],"balance_after":100000,"derivative":{"exercise_price":1.44,"expiration_date":"2035-04-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-25-012557","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925012557/rdgdoc.xml","form_type":"4"}},{"id":1168704,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T20:49:55.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026."}],"balance_after":350000,"derivative":{"exercise_price":1.44,"expiration_date":"2035-04-17","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001437749-25-012554","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925012554/rdgdoc.xml","form_type":"4"}},{"id":1168705,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80660,"kind":"person","name":"Nassif Freda","position":1,"cik":"0002045036","reported_name":"Nassif Freda","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T20:45:52.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026."}],"balance_after":100000,"derivative":{"exercise_price":1.44,"expiration_date":"2035-04-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-25-012549","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925012549/rdgdoc.xml","form_type":"4"}},{"id":1168703,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":74697,"kind":"person","name":"Cook Robert Christopher","position":1,"cik":"0001952028","reported_name":"Cook Robert Christopher","relationship":{"officer":true,"officer_title":"Chief Operating & Legal Office"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T20:43:54.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026."}],"balance_after":100000,"derivative":{"exercise_price":1.44,"expiration_date":"2035-04-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-25-012545","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925012545/rdgdoc.xml","form_type":"4"}},{"id":1345810,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:18:08.000Z","date":"2024-11-29","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":3.87,"value":15480.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-036551","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924036551/rdgdoc.xml","form_type":"4"}},{"id":1345809,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-03T21:16:07.000Z","date":"2024-11-29","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.18,"exercise_date":"2018-11-30","expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-24-036546","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924036546/rdgdoc.xml","form_type":"4"}},{"id":1345808,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:16:07.000Z","date":"2024-11-29","kind":"sale","planned":false,"acquired":false,"shares":59800,"price":3.86,"value":230828.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The sale reported in column 4 is a weighted average price. The shares were sold in multiple open market transactions at prices ranging from $3.81 to $3.89 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":11500,"source":{"system":"sec-edgar","filing":"0001437749-24-036546","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924036546/rdgdoc.xml","form_type":"4"}},{"id":1345807,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:16:07.000Z","date":"2024-11-29","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":3.82,"value":7640.0,"ownership":{"direct":false,"nature":"By limited liability corporation"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-036546","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924036546/rdgdoc.xml","form_type":"4"}},{"id":1345806,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:16:07.000Z","date":"2024-11-29","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":1.18,"value":59000.0,"ownership":{"direct":true},"balance_after":71300,"source":{"system":"sec-edgar","filing":"0001437749-24-036546","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924036546/rdgdoc.xml","form_type":"4"}},{"id":1357680,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85877,"kind":"person","name":"Landen Jaren","position":1,"cik":"0002045287","reported_name":"Landen Jaren","relationship":{"officer":true,"officer_title":"Chief Clinical Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-20T21:39:18.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025."}],"balance_after":85000,"derivative":{"exercise_price":27.95,"expiration_date":"2034-11-18","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001437749-24-035872","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924035872/rdgdoc.xml","form_type":"4"}},{"id":1357679,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80660,"kind":"person","name":"Nassif Freda","position":1,"cik":"0002045036","reported_name":"Nassif Freda","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-20T21:35:30.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025."}],"balance_after":100000,"derivative":{"exercise_price":27.95,"expiration_date":"2034-11-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-035868","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924035868/rdgdoc.xml","form_type":"4"}},{"id":1397145,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-01T20:37:36.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on July 15, 2025."}],"balance_after":600000,"derivative":{"exercise_price":27.42,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-24-030353","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924030353/rdgdoc.xml","form_type":"4"}},{"id":1412070,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-09T21:46:38.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date."}],"balance_after":100000,"derivative":{"exercise_price":26.91,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-028784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924028784/rdgdoc.xml","form_type":"4"}},{"id":1412069,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":74697,"kind":"person","name":"Cook Robert Christopher","position":1,"cik":"0001952028","reported_name":"Cook Robert Christopher","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-09T21:43:50.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date."}],"balance_after":100000,"derivative":{"exercise_price":26.91,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-028782","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924028782/rdgdoc.xml","form_type":"4"}},{"id":1412068,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-09T21:41:10.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date."}],"balance_after":100000,"derivative":{"exercise_price":26.91,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-028780","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924028780/rdgdoc.xml","form_type":"4"}},{"id":1505993,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:54:38.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four (4) years at a rate of 1/48th each full month."}],"balance_after":50000,"derivative":{"exercise_price":22.1,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-24-018027","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018027/rdgdoc.xml","form_type":"4"}},{"id":1505991,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:53:27.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four (4) years at a rate of 1/48th each full month."}],"balance_after":25000,"derivative":{"exercise_price":22.1,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-24-018024","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018024/rdgdoc.xml","form_type":"4"}},{"id":1505992,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":74697,"kind":"person","name":"Cook Robert Christopher","position":1,"cik":"0001952028","reported_name":"Cook Robert Christopher","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:52:33.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four (4) years at a rate of 1/48th each full month."}],"balance_after":10000,"derivative":{"exercise_price":22.1,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-018023","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018023/rdgdoc.xml","form_type":"4"}},{"id":1505988,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:51:41.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four (4) years at a rate of 1/48th each full month."}],"balance_after":10000,"derivative":{"exercise_price":22.1,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-018022","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018022/rdgdoc.xml","form_type":"4"}},{"id":1514796,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-16T23:13:35.000Z","date":"2024-05-16","kind":"gift","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001437749-24-017355","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924017355/rdgdoc.xml","form_type":"4"}},{"id":1514795,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-16T23:13:35.000Z","date":"2024-05-16","kind":"gift","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":950851,"source":{"system":"sec-edgar","filing":"0001437749-24-017355","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924017355/rdgdoc.xml","form_type":"4"}},{"id":1519530,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:19:58.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":15000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-24-016251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016251/rdgdoc.xml","form_type":"4"}},{"id":1519529,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79269,"kind":"person","name":"O DONNELL  MICHAEL J","position":1,"cik":"0001245266","reported_name":"O DONNELL  MICHAEL J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:19:06.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":10000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-016250","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016250/rdgdoc.xml","form_type":"4"}},{"id":1519528,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:17:23.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":15000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-24-016247","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016247/rdgdoc.xml","form_type":"4"}},{"id":1519527,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:15:42.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":15000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-24-016243","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016243/rdgdoc.xml","form_type":"4"}},{"id":1519526,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":77488,"kind":"person","name":"SCANNON PATRICK J MD PHD","position":1,"cik":"0001222790","reported_name":"SCANNON PATRICK J MD PHD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:14:35.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":10000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-016242","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016242/rdgdoc.xml","form_type":"4"}},{"id":1519525,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":72607,"kind":"person","name":"Anderson Robert Eugene Jr","position":1,"cik":"0002001911","reported_name":"Anderson Robert Eugene Jr","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:13:54.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":10000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-016241","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016241/rdgdoc.xml","form_type":"4"}},{"id":1519524,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":30157,"kind":"person","name":"Gravier Pierre","position":1,"cik":"0001984065","reported_name":"Gravier Pierre","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:11:48.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":10000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-016237","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016237/rdgdoc.xml","form_type":"4"}},{"id":1519523,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:05:03.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":10000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-016227","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016227/rdgdoc.xml","form_type":"4"}},{"id":1533070,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-30T13:13:43.000Z","date":"2024-04-26","kind":"exercise","planned":false,"acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":308740,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":69000},"source":{"system":"sec-edgar","filing":"0001437749-24-013866","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013866/rdgdoc.xml","form_type":"4"}},{"id":1533069,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-30T13:13:43.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":354740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":354740,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":532110},"source":{"system":"sec-edgar","filing":"0001437749-24-013866","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013866/rdgdoc.xml","form_type":"4"}},{"id":1533068,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-30T13:13:43.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By family"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":72000,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001437749-24-013866","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013866/rdgdoc.xml","form_type":"4"}},{"id":1533067,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-30T13:13:43.000Z","date":"2024-04-26","kind":"exercise","planned":false,"acquired":true,"shares":69000,"price":22,"value":1518000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":955851,"source":{"system":"sec-edgar","filing":"0001437749-24-013866","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013866/rdgdoc.xml","form_type":"4"}},{"id":1535604,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-25T13:15:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":117390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":0,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":176085},"source":{"system":"sec-edgar","filing":"0001437749-24-013144","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013144/rdgdoc.xml","form_type":"4"}},{"id":1535603,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-25T13:15:09.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":117390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":176085,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":176085},"source":{"system":"sec-edgar","filing":"0001437749-24-013144","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013144/rdgdoc.xml","form_type":"4"}},{"id":1535602,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-25T13:15:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":176085,"price":22,"value":3873870.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":469562,"source":{"system":"sec-edgar","filing":"0001437749-24-013144","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013144/rdgdoc.xml","form_type":"4"}},{"id":1537936,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-22T13:19:39.000Z","date":"2024-04-18","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":0,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-24-012643","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012643/rdgdoc.xml","form_type":"4"}},{"id":1537935,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-22T13:19:39.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents warrants that were originally issued on January 3, 2024 as a distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":1000,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-24-012643","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012643/rdgdoc.xml","form_type":"4"}},{"id":1537934,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-04-22T13:19:39.000Z","date":"2024-04-18","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":22,"value":33000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001437749-24-012643","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012643/rdgdoc.xml","form_type":"4"}},{"id":1540394,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-17T20:21:18.000Z","date":"2024-04-17","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":6920,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-24-012331","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012331/rdgdoc.xml","form_type":"4"}},{"id":1540393,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-17T20:21:18.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By limited liability corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":800,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001437749-24-012331","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012331/rdgdoc.xml","form_type":"4"}},{"id":1540392,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-17T20:21:18.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":7920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":7920,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":11880},"source":{"system":"sec-edgar","filing":"0001437749-24-012331","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012331/rdgdoc.xml","form_type":"4"}},{"id":1540391,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-17T20:21:18.000Z","date":"2024-04-17","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":22,"value":33000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":21300,"source":{"system":"sec-edgar","filing":"0001437749-24-012331","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012331/rdgdoc.xml","form_type":"4"}},{"id":1718228,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T22:06:37.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":20000,"derivative":{"exercise_price":21.71,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-034025","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923034025/rdgdoc.xml","form_type":"4"}},{"id":1719329,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":30157,"kind":"person","name":"Gravier Pierre","position":1,"cik":"0001984065","reported_name":"Gravier Pierre","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T21:57:42.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":20000,"derivative":{"exercise_price":21.71,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-033892","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923033892/rdgdoc.xml","form_type":"4"}},{"id":1719328,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":72607,"kind":"person","name":"Anderson Robert Eugene Jr","position":1,"cik":"0002001911","reported_name":"Anderson Robert Eugene Jr","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T21:55:42.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":20000,"derivative":{"exercise_price":21.71,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-033890","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923033890/rdgdoc.xml","form_type":"4"}},{"id":1765760,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":80661,"kind":"person","name":"Schoen Eric","position":1,"cik":"0001532303","reported_name":"Schoen Eric","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T22:36:03.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":150000,"derivative":{"exercise_price":17.54,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-23-027702","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923027702/rdgdoc.xml","form_type":"4"}},{"id":1765759,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":74697,"kind":"person","name":"Cook Robert Christopher","position":1,"cik":"0001952028","reported_name":"Cook Robert Christopher","relationship":{"officer":true,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T22:33:50.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":50000,"derivative":{"exercise_price":17.54,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-027700","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923027700/rdgdoc.xml","form_type":"4"}},{"id":1765758,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T22:29:27.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":150000,"derivative":{"exercise_price":17.54,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-23-027698","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923027698/rdgdoc.xml","form_type":"4"}},{"id":1765757,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T22:24:48.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":150000,"derivative":{"exercise_price":17.54,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-23-027696","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923027696/rdgdoc.xml","form_type":"4"}},{"id":1765756,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T22:24:48.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":300000,"derivative":{"exercise_price":17.54,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001437749-23-027696","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923027696/rdgdoc.xml","form_type":"4"}},{"id":1798036,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-24T20:06:00.000Z","date":"2023-08-23","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":17.45,"value":523500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple open market transactions at prices ranging from $17.21 to $17.64 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":886851,"source":{"system":"sec-edgar","filing":"0001069530-23-000045","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000045/certent-form4.xml","form_type":"4"}},{"id":1798960,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T20:58:25.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":16571,"price":16.65,"value":275907.15,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple open market transactions at prices ranging from $16.57 to $16.70 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":293477,"source":{"system":"sec-edgar","filing":"0001069530-23-000043","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000043/certent-form4.xml","form_type":"4"}},{"id":1798959,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T20:58:25.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":1906,"price":16.8,"value":32020.8,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":276906,"source":{"system":"sec-edgar","filing":"0001069530-23-000043","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000043/certent-form4.xml","form_type":"4"}},{"id":1859403,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":77488,"kind":"person","name":"SCANNON PATRICK J MD PHD","position":1,"cik":"0001222790","reported_name":"SCANNON PATRICK J MD PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:53:19.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0.95,"value":950.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":0.95,"exercise_date":"2022-09-14","expiration_date":"2028-09-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001069530-23-000037","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000037/certent-form4.xml","form_type":"4"}},{"id":1859402,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":77488,"kind":"person","name":"SCANNON PATRICK J MD PHD","position":1,"cik":"0001222790","reported_name":"SCANNON PATRICK J MD PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T20:53:19.000Z","date":"2023-06-12","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":0.95,"value":950.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001069530-23-000037","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000037/certent-form4.xml","form_type":"4"}},{"id":1878619,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T21:11:10.000Z","date":"2023-05-24","kind":"exercise","planned":false,"acquired":false,"shares":71428,"price":16.87,"value":1204990.36,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.87,"exercise_date":"2017-06-05","expiration_date":"2023-06-05","underlying":"Common Stock","underlying_shares":71428},"source":{"system":"sec-edgar","filing":"0001069530-23-000035","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000035/certent-form4.xml","form_type":"4"}},{"id":1878618,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T21:11:10.000Z","date":"2023-05-24","kind":"exercise","planned":false,"acquired":false,"shares":14285,"price":16.87,"value":240987.95,"ownership":{"direct":false,"nature":"By Family"},"balance_after":0,"derivative":{"exercise_price":16.87,"exercise_date":"2017-06-05","expiration_date":"2023-06-05","underlying":"Common Stock","underlying_shares":14285},"source":{"system":"sec-edgar","filing":"0001069530-23-000035","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000035/certent-form4.xml","form_type":"4"}},{"id":1878617,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-25T21:11:10.000Z","date":"2023-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":47723,"price":25.25,"value":1205005.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction."}],"balance_after":734279,"source":{"system":"sec-edgar","filing":"0001069530-23-000035","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000035/certent-form4.xml","form_type":"4"}},{"id":1878616,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-25T21:11:10.000Z","date":"2023-05-24","kind":"exercise","planned":false,"acquired":true,"shares":71428,"price":16.87,"value":1204990.36,"ownership":{"direct":true},"balance_after":782002,"source":{"system":"sec-edgar","filing":"0001069530-23-000035","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000035/certent-form4.xml","form_type":"4"}},{"id":1878615,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-25T21:11:10.000Z","date":"2023-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":9545,"price":25.25,"value":241011.25,"ownership":{"direct":false,"nature":"By Family"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction."}],"balance_after":380852,"source":{"system":"sec-edgar","filing":"0001069530-23-000035","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000035/certent-form4.xml","form_type":"4"}},{"id":1878614,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":90743,"kind":"person","name":"BARBIER REMI","position":1,"cik":"0001133806","reported_name":"BARBIER REMI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-25T21:11:10.000Z","date":"2023-05-24","kind":"exercise","planned":false,"acquired":true,"shares":14285,"price":16.87,"value":240987.95,"ownership":{"direct":false,"nature":"By Family"},"balance_after":390397,"source":{"system":"sec-edgar","filing":"0001069530-23-000035","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000035/certent-form4.xml","form_type":"4"}},{"id":1898464,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Opton (Right to Buy)","published_at":"2023-05-10T20:08:52.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":2142,"price":16.66,"value":35685.72,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.66,"exercise_date":"2017-06-14","expiration_date":"2023-06-14","underlying":"Common Stock","underlying_shares":2142},"source":{"system":"sec-edgar","filing":"0001069530-23-000033","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000033/certent-form4.xml","form_type":"4"}},{"id":1898463,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Opton (Right to Buy)","published_at":"2023-05-10T20:08:52.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":16.66,"value":59492.86,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.66,"exercise_date":"2017-06-14","expiration_date":"2023-06-14","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001069530-23-000033","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000033/certent-form4.xml","form_type":"4"}},{"id":1898462,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-10T20:08:52.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":19.6,"value":69991.6,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":19.6,"exercise_date":"2017-05-16","expiration_date":"2023-05-16","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001069530-23-000033","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000033/certent-form4.xml","form_type":"4"}},{"id":1898461,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:08:52.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":2142,"price":16.66,"value":35685.72,"ownership":{"direct":true},"balance_after":856851,"source":{"system":"sec-edgar","filing":"0001069530-23-000033","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000033/certent-form4.xml","form_type":"4"}},{"id":1898460,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:08:52.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":3571,"price":16.66,"value":59492.86,"ownership":{"direct":true},"balance_after":854709,"source":{"system":"sec-edgar","filing":"0001069530-23-000033","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000033/certent-form4.xml","form_type":"4"}},{"id":1898459,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T20:08:52.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":3571,"price":19.6,"value":69991.6,"ownership":{"direct":true},"balance_after":851138,"source":{"system":"sec-edgar","filing":"0001069530-23-000033","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000033/certent-form4.xml","form_type":"4"}},{"id":1901291,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":77488,"kind":"person","name":"SCANNON PATRICK J MD PHD","position":1,"cik":"0001222790","reported_name":"SCANNON PATRICK J MD PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:14:36.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":22.34,"value":446800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest over a three (3) year period at a rate of 1/36th per month."}],"balance_after":20000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001069530-23-000031","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000031/certent-form4.xml","form_type":"4"}},{"id":1901290,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:13:18.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":22.34,"value":111700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest over a one (1) year period at a rate of 1/12th per month."}],"balance_after":5000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001069530-23-000029","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000029/certent-form4.xml","form_type":"4"}},{"id":1901289,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":15344,"kind":"person","name":"ROBERTSON SANFORD","position":1,"cik":"0001250105","reported_name":"ROBERTSON SANFORD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:13:18.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":22.34,"value":446800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest over a three (3) year period at a rate of 1/36th per month."}],"balance_after":25000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001069530-23-000029","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000029/certent-form4.xml","form_type":"4"}},{"id":1901288,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79269,"kind":"person","name":"O DONNELL  MICHAEL J","position":1,"cik":"0001245266","reported_name":"O DONNELL  MICHAEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:10:42.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":22.34,"value":446800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest over a three (3) year period at a rate of 1/36th per month."}],"balance_after":20000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001069530-23-000027","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000027/certent-form4.xml","form_type":"4"}},{"id":1901287,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:08:37.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":22.34,"value":111700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest over a one (1) year period at a rate of 1/12th per month."}],"balance_after":5000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001069530-23-000025","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000025/certent-form4.xml","form_type":"4"}},{"id":1901286,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:08:37.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":22.34,"value":446800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest over a three (3) year period at a rate of 1/36th per month."}],"balance_after":25000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001069530-23-000025","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000025/certent-form4.xml","form_type":"4"}},{"id":1901285,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:06:37.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":22.34,"value":111700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest over a one (1) year period at a rate of 1/12th per month."}],"balance_after":5000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001069530-23-000023","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000023/certent-form4.xml","form_type":"4"}},{"id":1901284,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:06:37.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":22.34,"value":446800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest over a three (3) year period at a rate of 1/36th per month."}],"balance_after":25000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001069530-23-000023","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000023/certent-form4.xml","form_type":"4"}},{"id":1908997,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-02T20:04:00.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":19.6,"value":69991.6,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":19.6,"exercise_date":"2017-05-16","expiration_date":"2023-05-16","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001069530-23-000019","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000019/certent-form4.xml","form_type":"4"}},{"id":1908996,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-02T20:04:00.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":16.66,"value":59492.86,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.66,"exercise_date":"2017-06-14","expiration_date":"2023-06-14","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001069530-23-000019","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000019/certent-form4.xml","form_type":"4"}},{"id":1908995,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-02T20:04:00.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":2142,"price":16.66,"value":35685.72,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.66,"exercise_date":"2017-06-14","expiration_date":"2023-06-14","underlying":"Common Stock","underlying_shares":2142},"source":{"system":"sec-edgar","filing":"0001069530-23-000019","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000019/certent-form4.xml","form_type":"4"}},{"id":1908994,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:04:00.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":true,"shares":7077,"price":23.34,"value":165177.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction."}],"balance_after":10617,"source":{"system":"sec-edgar","filing":"0001069530-23-000019","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000019/certent-form4.xml","form_type":"4"}},{"id":1908993,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":79270,"kind":"person","name":"GUSSIN ROBERT Z","position":1,"cik":"0001245263","reported_name":"GUSSIN ROBERT Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:04:00.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":3571,"price":19.6,"value":69991.6,"ownership":{"direct":true},"balance_after":17694,"source":{"system":"sec-edgar","filing":"0001069530-23-000019","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000019/certent-form4.xml","form_type":"4"}}],"next_cursor":"2023-05-02T20:04:00.000000Z,1908993"}